Related references
Note: Only part of the references are listed.ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells
Yusuke Takeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Role of Iron and Nerve Inflammation in Diabetes Mellitus Type 2-Induced Peripheral Neuropathy
Sabine Paeschke et al.
NEUROSCIENCE (2019)
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Hiddo J. L. Heerspink et al.
DIABETOLOGIA (2019)
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
Monika A. Niewczas et al.
NATURE MEDICINE (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
Carol Pollock et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial
Julio Rosenstock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Verapamil Attenuated Prediabetic Neuropathy in High-Fat Diet-Fed Mice through Inhibiting TXNIP-Mediated Apoptosis and Inflammation
Lingling Xu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells
Toshinobu Maki et al.
SCIENTIFIC REPORTS (2019)
Inflammation in Diabetic Kidney Disease
Rosa E. Perez-Morales et al.
NEPHRON (2019)
The Promise of Systems Biology for Diabetic Kidney Disease
Frank C. Brosius et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2018)
The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
Keizo Kanasaki
CLINICAL SCIENCE (2018)
M1/M2 Macrophages in Diabetic Nephropathy: Nrf2/HO-1 as Therapeutic Targets
Robert Clive Landis et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
Merlin C. Thomas et al.
DIABETOLOGIA (2018)
AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions
Davoud Sanajou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
W. Timothy Garvey et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Katherine R. Tuttle et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose
Can Wu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease
Bancha Satirapoj et al.
BMC NEPHROLOGY (2018)
Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms
Iolanda Lazaro et al.
FRONTIERS IN PHARMACOLOGY (2018)
Macrophages in diabetic nephropathy in patients with type 2 diabetes
Celine Q. F. Klessens et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
C-C motif-ligand 2 inhibition with emapticap pegol ( NOX-E36) in type 2 diabetic patients with albuminuria
Jan Menne et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Characterization and comparison of SGLT2 inhibitors: Part 3. Effects on diabetic complications in type 2 diabetic mice
Atsuo Tahara et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
Daiji Kawanami et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Allison B. Goldfine et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice
Hongyu Zhang et al.
KIDNEY INTERNATIONAL (2017)
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
Liang Xu et al.
EBIOMEDICINE (2017)
Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets
Raimund Pichler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial
Girish N. Nadkarni et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Inflammation as a Therapeutic Target for Diabetic Neuropathies
Rodica Pop-Busui et al.
CURRENT DIABETES REPORTS (2016)
Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men
M. H. A. Muskiet et al.
DIABETES OBESITY & METABOLISM (2016)
Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease
Michelle J. Pena et al.
DIABETOLOGIA (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Eri H. Kobayashi et al.
NATURE COMMUNICATIONS (2016)
Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
Olga Simo-Servat et al.
JOURNAL OF DIABETES RESEARCH (2016)
Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence
Daiji Kawanami et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients
Radovan Hojs et al.
NEPHRON (2016)
Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in Asians with type 2 diabetes
Jian-Jun Liu et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Mycophenolate Mofetil Ameliorates Diabetic Nephropathy in db/db Mice
Jung-Woo Seo et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
Stephanie Toth-Manikowski et al.
JOURNAL OF DIABETES RESEARCH (2015)
Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
Sathish Babu Vasamsetti et al.
DIABETES (2015)
Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury
Yoshiki Higashijima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus
Keith C. Ferdinand et al.
HYPERTENSION (2014)
The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
Hiroki Fujita et al.
KIDNEY INTERNATIONAL (2014)
Rho-kinase regulation of TNF-α-induced nuclear translocation of NF-κB RelA/p65 and M-CSF expression via p38 MAPK in mesangial cells
Keiichiro Matoba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
Volker Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
M. Barbieri et al.
ATHEROSCLEROSIS (2013)
Fasudil inhibits ER stress-induced VCAM-1 expression by modulating unfolded protein response in endothelial cells
Daiji Kawanami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: A prospective study
Jacobien C. Verhave et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α
Keiichiro Matoba et al.
KIDNEY INTERNATIONAL (2013)
Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-kappa B pathways in diabetic neuropathy
Veera Ganesh Yerra et al.
REDOX BIOLOGY (2013)
Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
Swenja Kroeller-Schoen et al.
CARDIOVASCULAR RESEARCH (2012)
Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
Monika A. Niewczas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Inflammation in Diabetic Nephropathy
Andy K. H. Lim et al.
MEDIATORS OF INFLAMMATION (2012)
Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
Sridevi Devaraj et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells
Daiji Kawanami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Hongting Zheng et al.
DIABETES (2011)
Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
Kathrin Eller et al.
DIABETES (2011)
Transcriptome Analysis of Human Diabetic Kidney Disease
Karolina I. Woroniecka et al.
DIABETES (2011)
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
R. Kodera et al.
DIABETOLOGIA (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-κB p65
Hideaki Shimada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Critical role for osteopontin in diabetic nephropathy
Susanne B. Nicholas et al.
KIDNEY INTERNATIONAL (2010)
Dose- and time-dependent glucocorticoid receptor signaling in podocytes
Adam Guess et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
A. K. H. Lim et al.
DIABETOLOGIA (2009)
Microvascular Reactivity and Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy
John Doupis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-κB p65 signaling
Catherine Meyer-Schwesinger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice
Cheol Whee Park et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Macrophage scavenger receptor-A-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation
Hitorni Kataoka Usui et al.
DIABETES (2007)
Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase
Toru Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat
B Rodriguez-Iturbe et al.
KIDNEY INTERNATIONAL (2005)
Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes
S Okada et al.
DIABETES (2003)
Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-κB pathways
DZ Zhao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation
DM Lenda et al.
JOURNAL OF IMMUNOLOGY (2003)
Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes
R Utimura et al.
KIDNEY INTERNATIONAL (2003)
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
AI Adler et al.
KIDNEY INTERNATIONAL (2003)
Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy
P Clausen et al.
DIABETIC MEDICINE (2000)
Share Paper
